bDMARDrheumatoid arthritisspondyloarthritisSpARAGR2- NCT02450396
…ents continued a biologic Disease-Modifying Antirheumatic Drug (bDMARD) during the whole pregnancy and the postpartum. 78/91 RA and 94…
7articles mentioning drugs
15drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: bDMARD ×
bDMARD
This drug is selected. Its supporting articles are shown below.
Articles mentioning bDMARD
7 articles · page 1 of 1bDMARDpsoriatic arthritis (PsA)PsA
…e load before pregnancy constituted risk factors. Discontinuing bDMARD treatment in early pregnancy further increased the risk. Our fi…
bDMARDr-axSpAAnkylosing Spondylitis Disease Activity Score
…tients with r-axSpA and active disease at baseline initiating a bDMARD were included in this analysis. Vitamin D (25-hydroxyvitamin D)…
bDMARDsbDMARDSpAspondyloarthritis (SpA)REGISPON-3
…ciation between biologic disease-modifying antirheumatic drugs (bDMARDs) exposure and functional change in a sex-dependent manner.Metho…
bDMARDcsDMARDHealth Assessment QuestionnaireSystemic sclerosis (SSc)Visual Analogue Scale
…05±0.6;p=0.006], GI involvement [1.78±0.7;p=0.02], and those on bDMARD therapy [2.80±0.2; p=0.002]. A correlation was also found with …
bDMARDbDMARDsDisease Activity Score 28synovitisarthritisEuropean Alliance of Associations for RheumatologyEULAREULAR-OMERACTOMERACT
…e validity for biological disease-modifying antirheumatic drug (bDMARD) discontinuation and for flares while tapering bDMARDs. In addi…
rituximabBelimumabcyclophosphamideBLMbDMARD
…s received BLM after bDMARD. The main bDMARD use before BLM was rituximab in the 85.3% of patients. Baseline characteristics are summariz…